Pushcom Bio completed C+ round of financing of over 100 million yuan
Pushcom Bio is a high-tech enterprise based on in vitro diagnosis (IVD). The company uses the world’s leading microfluidic disk chip platform technology, combined with the original micro whole blood separation function, to develop coagulation, immunity, biochemistry, Molecular diagnostic kits and new supporting detection systems. Recently, Pushkang Bio completed the C+ round of financing of […]
Pushcom Bio completed C+ round of financing of over 100 million yuan Read More »